Table 2. Comparison of clinical and laboratory characteristics, initial parameters of the InsulinAPP protocol and follow-up of individuals with type 2 diabetes who used basal-bolus, bolus-correction insulin therapy regimens and that required a change from the bolus-correction to basal-bolus regimen in the first ten days of the protocol.

Variable		Bolus-correction insulin regimen (n = 33)	Change from bolus-correction to basal-bolus (n = 40)	Basal-bolus insulin regimen (n = 69)	P
Admission BG, mg/dL		148.0 (72.0)	199.5 (86.0)	248.0 (130.5)	<0.001 †
HbA1c, %		6.6% (1.5%)	8.0% (2.8%)	9.4% (4.2%)	<0.001 †
InsulinAPP protocol
	BG measurements	741	968	1484
	BG measurements per individual	22.5	24.2	21.5
	Hypoglycemia episodes	10 (1.3%)	12 (1.2%)	27 (1.8%)
	% hypoglycemia per individual	0% (0.03%)	0% (0%)	0% (0.04%)	0.586 †
	BG episodes 70-180 mg/dL	647 (87.3%)	730 (75.4%)	871 (58.7%)
	% BG 70-180 mg/dL	93.3 (14.3)	76.7 (23.5)	65.0 (40.9)	<0.001 †
Follow-up
	Hospital discharge	28 (84.8%)	38 (95.0%)	63 (91.3%)	0.310 *
	Transfer to another ward	6 (18.2%)	3 (7.5%)	10 (14.5%)	0.428 ‡
	ICU transfer	4 (12.1%)	2 (5.0%)	2 (2.9%)	0.173 ‡
	Indication of palliative care	2 (6.1%)	1 (2.5%)	3 (4.3%)	0.757 ‡
	Deaths	5 (15.2%)	2 (5.0%)	6 (8.7%)	0.310 ‡

Data are median (interquartile range) or n (%).

^*Pearson’s chi-squared test.

^†Kruskal-Wallis rank-sum test.

^‡Fisher’s exact test.

BG: blood glucose; ICU: intensive care unit.